Two million Canadians using GLP-1 drugs like Ozempic are dramatically changing food consumption patterns, removing $3.3 billion annually from Canada's food economy. Learn how this trend affects groceries, restaurants and agriculture.
Learn the correct methods for disposing expired or unused medications in Canada. Protect your family and environment with proper drug disposal practices.
A mother's journey through her son's epilepsy diagnosis and her own panic attacks reveals how maternal instinct led to life-changing treatment during Epilepsy Awareness Month.
Discover why some patients experience hair loss while taking GLP-1 medications like Ozempic. Learn about the science behind this side effect and expert recommendations.
Health officials warn about counterfeit Dilaudid pills circulating in Nova Scotia after suspected fatal overdose. Learn how to identify fake medications and protect yourself.
Pfizer triumphs in dramatic $10 billion bidding war for obesity drug maker Metsera, securing crucial White House-backed deal to compete in weight-loss market. Read the full story.
Former President Donald Trump unveils ambitious strategy to dramatically reduce costs of groundbreaking weight-loss medications, promising relief for millions struggling with obesity.
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giant to make obesity drugs more affordable and accessible across the United States.
Major pharmaceutical giants Novo Nordisk and Eli Lilly experience significant stock surges as former President Donald Trump considers a groundbreaking obesity drug partnership, potentially revolutionizing weight loss treatment accessibility.
A Steinbach family celebrates as the Manitoba government approves coverage for a costly medication that could save their son's life after months of uncertainty and desperate appeals.
A crucial witness in a Saskatoon murder trial faces credibility challenges after admitting to being heavily medicated during court testimony, raising questions about the case's integrity.
Critical shortages of hydromorphone and other essential pain medications continue to plague Canadian pharmacies, leaving patients scrambling as supply chain issues persist.
Health Canada issues urgent recall for specific blood pressure medications containing potentially carcinogenic nitrosamine impurity. Learn which lots are affected and what steps to take.
Pharmaceutical giant Eli Lilly reports explosive growth driven by Mounjaro and Zepbound, creating intense investor competition and reshaping the obesity treatment landscape.
Pharmaceutical giants and startups race to develop next-generation weight-loss treatments as demand soars and market valuations skyrocket in this healthcare revolution.
New Canadian research exposes the limitations of BMI, revealing millions with normal weight may have 'hidden obesity' and face serious health risks. Discover the silent epidemic your scale isn't showing you.